SCHEMBL21875627

SCHEMBL21875627

Nc1nc(CC(=O)NC2CCN(C3CCCCC3)CC2)cs1

nearest known ligand 0.51

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 1/20 0.51
▸ ALDH1A1 P00352 1/20 0.51
▸ TSHR P16473 1/20 0.51
▸ ACKR3 P25106 6/20 0.47
▸ SIGMAR1 Q99720 4/20 0.45
▸ HSD17B10 Q99714 2/20 0.45
▸ GABRA5 P31644 1/20 0.45
▸ GABRB2 P47870 1/20 0.45
▸ HPGD P15428 1/20 0.42
▸ PARP1 P09874 1/20 0.41
▸ CHRM5 P08912 2/20 0.39
▸ CHRM1 P11229 2/20 0.39
▸ CHRM2 P08172 1/20 0.39
▸ CHRM4 P08173 1/20 0.39
▸ CHRM3 P20309 1/20 0.39
▸ POLB P06746 1/20 0.39
▸ KCNJ6 P48051 1/20 0.39
▸ KCNJ3 P48549 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20640361 0.83 ALDH1A1 (0.44) KDM4EALDH1A1ACKR3SIGMAR1HPGD
SCHEMBL20640293 0.81 KDM4E (0.51) KDM4EALDH1A1TSHRHSD17B10GABRA5
SCHEMBL28399201 0.78 OPRM1 (0.46) ALDH1A1ACKR3SIGMAR1HPGDKCNJ6
SCHEMBL19820647 0.76 HSD17B10 (0.47) KDM4EALDH1A1HSD17B10GABRA5GABRB2
Hydrochloric Acid SCHEMBL20640317 0.75 HSD17B10 (0.46) KDM4EALDH1A1HSD17B10GABRA5GABRB2
Hydrochloric Acid SCHEMBL19814023 0.75 HSD17B10 (0.46) KDM4EALDH1A1HSD17B10GABRA5GABRB2
SCHEMBL5240163 0.74 GABRA5 (0.50) KDM4EALDH1A1TSHRHSD17B10GABRA5
SCHEMBL20640319 0.73 LMNA (0.41) KDM4EALDH1A1TSHRHSD17B10GABRA5
SCHEMBL20640322 0.73 LMNA (0.41) KDM4EALDH1A1TSHRHSD17B10GABRA5
SCHEMBL20648977 0.72 F2 (0.46) KDM4EALDH1A1HSD17B10GABRA5GABRB2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-110997678-B Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2023-02-21 — — CN disclosed
US-11117901-B2 Substituted pyrazolo[4,3-h]quinazolines as choline kinase inhibitors NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2021-09-14 — — US disclosed
US-20200131188-A1 PYRAZOLO-QUINAZOLINE DERIVATIVES AS CHOLINE KINASE INHIBITORS NERVIANO MEDICAL SCIENCES S.R.L. (IT) 2020-04-30 — — US disclosed
CN-110997678-A Pyrazoloquinazoline derivatives as choline kinase inhibitors 内尔维亚诺医疗科学公司 2020-04-10 — — CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20200131188-A1 PYRAZOLO-QUINAZOLINE DERIVATIVES AS CHOLINE KINASE INHIBITORS CHKA, CHKB, NADK KDM4E 924/4885ALDH1A1 2929/4885TSHR 4297/4885
US-11117901-B2 Substituted pyrazolo[4,3-h]quinazolines as choline kinase inhibitors CHKA, CHKB, NADK KDM4E 876/4885ALDH1A1 2234/4885TSHR 4044/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback